Tandem Diabetes Care has received authorization of sale by Health Canada, paving the way for in-warranty t:slim X2 insulin pump users to be full compatibility with both the Dexcom G7 and Dexcom G6 ...

Glucagon-like peptide 1 receptor agonists and fenofibrates may protect patients with type 2 diabetes against diabetic macular ...

Investing in grocery stores and safe spaces to exercise, and providing more cost-sharing for diabetes care would pay off in better health outcomes longterm.

OTR Global has a Positive read on Tandem Diabetes (TNDM) and Insulet (PODD) after interviews with U.S. endocrinology practitioners that showed ...

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its stake in Tandem Diabetes Care, Inc. (NASDAQ:TNDM ...

Tandem Diabetes Care announced today that t:slim X2 insulin pump users in Canada can now access full compatibility with ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...

Fmr LLC decreased its holdings in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) by 36.7% during the 3rd ...

Tandem Diabetes Care (TNDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The latest addition to the pump platform portfolio, Tandem Mobi, is leading the way in creating a whole new category of devices for insulin therapy. The company’s extended wear infusion set technology ...

Fintel reports that on December 2, 2024, Morgan Stanley upgraded their outlook for Tandem Diabetes Care (NasdaqGM:TNDM) from ...

Leerink Partners analyst Mike Kratky maintained a Buy rating on Tandem Diabetes Care (TNDM – Research Report) on November 25 and set a price ...